Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Vertex Pharmaceuticals, Inc. (NQ: VRTX)
79.47 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Vertex Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
May 17, 2013
from Business Wire News Releases
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
May 09, 2013
from Business Wire News Releases
Free Research Reports on AVEO, CXO, MWW and VRTX Issued by the Paragon Report
May 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Vertex Reports First Quarter 2013 Financial Results and Reviews Recent Progress in Development Programs for Cystic Fibrosis and Hepatitis C
April 30, 2013
from Business Wire News Releases
Vertex Announces New Data that Showed High Viral Cure Rates with a Total of 12 and 24 Weeks of Telaprevir Combination Treatment Among People with Genotype 1 Hepatitis C Who Have the IL28B CC Genotype
April 24, 2013
from Business Wire News Releases
Netflix Indicating Big Jump Pre-Market on Earnings Surprise - Top Earnings Stocks Ahead of the Bell: Power-One Inc., Goff Corporation, AMR Corporation, Fannie Mae, Vertex Pharmaceuticals
April 23, 2013
from PR Newswire
ALS-2200 (VX-135) Viral Kinetic Study Shows Significant Reduction in HCV RNA in People with Genotype 1 Hepatitis C Virus Infection and Cirrhosis, and in People with Genotypes 2, 3 or 4 HCV Infection
April 23, 2013
from Business Wire News Releases
Today's Earnings Forecast for EMC, Intel, Cisco, Dell, Vertex Pharmaceuticals, and International Business Machines
April 22, 2013
from PR Newswire
The Market Rebounds and Sea World Makes its Debut
April 22, 2013
from PR Newswire
Cheaper Gas, Airfare, Profits on Way as Commodities Slump Continues? - Top Small Cap Stock Focus Ahead of the Bell:
April 22, 2013
Harbor Island Development, Goff Corporation, AMR Corporation, Fannie Mae, Vertex Pharmaceuticals Read More
from PR Newswire
Free Research Reports on AMD, MSFT, PRGX and VRTX Issued by the Bedford Report
April 22, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Vertex Pharmaceuticals Inc. and Intel Corporation Analysis Review: (NASDAQ: VRTX), (NASDAQ: INTC)
April 19, 2013
from SBWire Direct - Latest Press Releases
Treatment with VX-661 and Ivacaftor in a Phase 2 Study Resulted in Statistically Significant Improvements in Lung Function in People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation
April 18, 2013
from Business Wire News Releases
Unica Founder Yuchun Lee Joins General Catalyst Partners
April 11, 2013
from Business Wire News Releases
Vertex Enters Agreement with Bristol-Myers Squibb for Phase 2 All-Oral Studies of VX-135 in Combination with Daclatasvir for the Treatment of Hepatitis C
April 05, 2013
from Business Wire News Releases
Vertex to Report First Quarter 2013 Financial Results on Tuesday, April 30
April 01, 2013
from Business Wire News Releases
Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics
April 01, 2013
from PR Newswire
Pushing Pipelines Forward for Long-Term Success - Research Report on Vertex, Santarus, Arena Pharmaceuticals, Seattle Genetics and Nektar Therapeutics
March 08, 2013
from PR Newswire
FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing
March 07, 2013
Five Star Equities Provides Stock Research on Medivation and Vertex Pharmaceuticals Read More
from Marketwired News Releases
VX-787 Showed Significant Antiviral Activity and Reduced the Severity and Duration of Influenza Symptoms in Phase 2 Challenge Study
March 04, 2013
from Business Wire News Releases
Before the Bell Scans of Affymax, Questcor Pharma, Gilead Sciences, Vertex Pharma, and Optimer Pharma
March 01, 2013
from PR Newswire
Vertex Announces Webcasts of its Presentations at Two Investor Conferences
February 27, 2013
from Business Wire News Releases
Vertex Announces Initiation of Pivotal Phase 3 Program of VX-809 in Combination with Ivacaftor for the Treatment of People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation
February 26, 2013
from Business Wire News Releases
Republic of Ireland Approves Funding for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People with a Specific Genetic Mutation (G551D)
February 01, 2013
from Business Wire News Releases
FDA Approved a Total of 39 New Drugs in 2012 -- Fifteen Year High
February 01, 2013
Research Driven Investing Provides Stocks Research on Aegerion and Vertex Read More
from Marketwired News Releases
The Real Story Behind RIG, CMI, VRTX and TSO
February 01, 2013
from Marketwired News Releases
Free Research Reports on ADT, CHK, MTOR and VRTX Issued by the Bedford Report
January 31, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Vertex Reports Full-Year and Fourth Quarter 2012 Financial Results and Provides Updates on Key Development Programs
January 29, 2013
from Business Wire News Releases
Free Research Reports on RSYS, SNTS, VPHM and VRTX Issued by the Bedford Report
January 16, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Vertex to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, January 29
January 15, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The New Microsoft Xbox One: Key Takeaways (and Red Flags) From Today's Announcement
Jake Barach and Nick Shchteko
2
Gold Mining Stocks: 10 Reasons It's Time to Be Brave
David Banister
3
6 Healthy Products That Aren't
Diane Bullock
4
Random Thoughts: A Signal That Bears Watching
Todd Harrison
5
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper

Financial Product Guide